GLP-1 receptor agonists show promise in treating substance use disorders
A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are inconsistent due ...
Tag: Glycated hemoglobin
Oral semaglutide outperforms other medications in type 2 diabetes treatment, significantly reducing HbA1c and body weight
A study analyzing the PIONEER trial data claims that orally administered semaglutide is highly effective in reducing glycated hemoglobin (HbA1c) ...
SCORE2- diabetes prediction model estimates the 10 year risk of cardiovascular disease in individuals with type 2 diabetes
In a recent study published in the European Heart Journal, researchers described the development and validation process of SCORE2-Diabetes, a ...
Glucokinase activator AZD1656 shows potential benefit for diabetics with moderate to severe COVID-19
Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a wide range of clinical features, from completely asymptomatic ...
